PM
NVAX icon

Parametrica Management’s Novavax NVAX Stock Holding History

Parametrica Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,539
Closed -$703K – 271
2022
Q1 		$703K Buy
9,539
+7,733
+428% +$690K 0.52% 36
2021
Q4 		$258K Sell
1,806
-58,490
-97% -$10M 0.26% 41
2021
Q3 		$12.5M Buy
60,296
+50,096
+491% +$11M 9.33% 2
2021
Q2 		$2.17M Buy
10,200
+8,917
+695% +$1.63M 1.6% 19
2021
Q1 		$222K Buy
+1,283
New +$256K 0.11% 138
2016
Q4 		– Sell
-1,526
Closed -$63K – 247
2016
Q3 		$63K Buy
1,526
+38
+3% +$4.91K 0.17% 127
2016
Q2 		$216K Buy
1,488
+448
+43% +$51.3K 0.32% 164
2016
Q1 		$107K Buy
+1,040
New +$112K 0.38% 98
2015
Q4 		– Sell
-3,094
Closed -$438K – 84
2015
Q3 		$438K Buy
+3,094
New +$694K 2.76% 4
2014
Q4 		– Sell
-927
Closed -$77K – 66
2014
Q3 		$77K Buy
+927
New +$83.8K 0.45% 59

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parametrica Management's NVAX Position: Q2 2022 in Review

Parametrica Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 9,539 shares — an estimated $703K sold.

Parametrica Management first reported a position in NVAX in Q3 2014 and held it in 10 quarters. The position peaked at $12.5M in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Parametrica Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Parametrica Management sold 9,539 Novavax shares in Q2 2022, an estimated $703K.
  • Parametrica Management first reported a position in Novavax in Q3 2014 and held it in 10 quarters.
  • Parametrica Management's Novavax position peaked at $12.5M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Parametrica Management's 13F filing for Q2 2022, filed 22 Jul 2022.